(2026). Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Worth Their Weight in Gray Matter? A Narrative Review of Cost‐effectiveness Analyses of Monoclonal Antibodies for Alzheimer's Disease."
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Worth Their Weight in Gray Matter? A Narrative Review of Cost‐effectiveness Analyses of Monoclonal Antibodies for Alzheimer's Disease."
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.